Neurotoxicity characterized after infusion of CD19 CAR-T cells – Medical Xpress
Medical Xpress |
Neurotoxicity characterized after infusion of CD19 CAR–T cells
Medical Xpress Juliane Gust, M.D., Ph.D., from the University of Washington in Seattle, and colleagues characterized neurologic adverse events in 133 adults with refractory B-cell malignancies treated with lymphodepletion chemotherapy followed by infusion of CD19 CAR … Averting toxic side effects from CAR–T cancer treatments |
